GR3019522T3 - Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material - Google Patents

Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material

Info

Publication number: GR3019522T3
Authority: GR; Greece
Prior art keywords: depot; pct; retard; materials; systems
Prior art date: 1991-04-17

Application number

GR960400911T

Other languages

English (en)

Inventor

Wolfgang Ritter

Rudolf Lehmann

Rainer Sorg

Original Assignee

Henkel Kgaa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-04-17

Filing date

1996-04-02

Publication date

1996-07-31

1996-04-02 Application filed by Henkel Kgaa filed Critical Henkel Kgaa

1996-07-31 Publication of GR3019522T3 publication Critical patent/GR3019522T3/el

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/13—Burn treatment
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31786—Of polyester [e.g., alkyd, etc.]

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Materials Engineering (AREA)
Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Treatments Of Macromolecular Shaped Articles (AREA)
Chemical Or Physical Treatment Of Fibers (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GR960400911T 1991-04-17 1996-04-02 Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material GR3019522T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4112464A DE4112464A1 (de)	1991-04-17	1991-04-17	Verbesserte retard-systeme fuer die zeitverzoegerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-traegermaterial
PCT/EP1992/000825 WO1992018108A1 (de)	1991-04-17	1992-04-11	Verbesserte retard-systeme für die zeitverzögerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-trägermaterial

Publications (1)

Publication Number	Publication Date
GR3019522T3 true GR3019522T3 (en)	1996-07-31

Family

ID=6429738

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR960400911T GR3019522T3 (en)	1991-04-17	1996-04-02	Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material

Country Status (14)

Country	Link
US (1)	US5538738A (el)
EP (1)	EP0580689B1 (el)
JP (1)	JP3351523B2 (el)
AT (1)	ATE133857T1 (el)
AU (1)	AU661303B2 (el)
BR (1)	BR9205903A (el)
CA (1)	CA2108680A1 (el)
DE (2)	DE4112464A1 (el)
DK (1)	DK0580689T3 (el)
ES (1)	ES2083167T3 (el)
FI (1)	FI934569A0 (el)
GR (1)	GR3019522T3 (el)
NO (1)	NO933345D0 (el)
WO (1)	WO1992018108A1 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19646782C2 (de) *	1996-11-13	2000-05-25	Merck Patent Gmbh	Bioresorbierbare Polymerisationsprodukte aus strahlungshärtbaren Bindemittelsystemen
US7056893B2 (en) *	1999-03-31	2006-06-06	Insite Vision, Inc.	Topical treatment for prevention of ocular infections
GB0007419D0 (en) †	2000-03-27	2000-05-17	Smithkline Beecham Gmbh	Composition
CZ294328B6 (cs) *	2002-08-22	2004-11-10	Pliva-Lachema A. S.	Biodegradabilní kompozice s prolongovaným uvolňováním biologicky aktivní látky a způsob její výroby
EP3103422A1 (en) *	2003-03-14	2016-12-14	Intersect ENT, Inc.	Sinus delivery of sustained release therapeutics
RU2007140909A (ru)	2005-04-04	2009-05-20	Синексус, Инк. (Us)	Устройство и способы лечения заболеваний околоносовых пазух
US20090181075A1 (en) *	2005-07-15	2009-07-16	Gordon Ryan D	Drospirenone containing transdermal drug delivery devices and methods of delivery thereof
US8535707B2 (en)	2006-07-10	2013-09-17	Intersect Ent, Inc.	Devices and methods for delivering active agents to the osteomeatal complex
US20090198179A1 (en)	2007-12-18	2009-08-06	Abbate Anthony J	Delivery devices and methods
CA2732355A1 (en)	2008-08-01	2010-02-04	Intersect Ent, Inc.	Methods and devices for crimping self-expanding devices
AU2009319183B2 (en)	2008-11-27	2014-06-05	B.R.A.I.N. Biotechnology Research And Information Network Ag	Hydrophobins as surface active proteins as excipients in solid pharmaceutical formulations
EP2429624B1 (en)	2009-05-15	2014-04-02	Intersect ENT, Inc.	A combination of an expandable device and a delivery device.
US10406332B2 (en)	2013-03-14	2019-09-10	Intersect Ent, Inc.	Systems, devices, and method for treating a sinus condition
TWI503625B (zh)	2013-08-23	2015-10-11	Ind Tech Res Inst	感光性組成物與光阻
EP3936166B1 (en)	2015-01-22	2023-12-20	Intersect ENT, Inc.	Drug-coated expandable device for treating a nasal, an otic, or a throat condition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2807132C2 (de) *	1978-02-20	1983-11-03	Battelle-Institut E.V., 6000 Frankfurt	Implantierbares Pharmaka-Depot
DE3204504A1 (de) *	1982-02-10	1983-08-18	Henkel KGaA, 4000 Düsseldorf	Neue schwerfluechtige mono- und/oder bis-(meth)-acrylate und ihre verwendung
ATE19095T1 (de) *	1982-02-10	1986-04-15	Henkel Kgaa	Chirurgische bindemittelsysteme zum verkleben von koerpereigenem hartgewebe gewuenschtenfalls mit kunststoff und/oder metall.
DE3716302C2 (de) *	1987-05-15	1996-02-01	Henkel Kgaa	Verbesserte resorbierbare Knochenwachse und ihre Verwendung
DE3825211A1 (de) *	1988-07-25	1990-02-01	Henkel Kgaa	Verbesserte koerperresorbierbare knochenwachse (iii)
DE3939161A1 (de) *	1989-11-27	1991-05-29	Henkel Kgaa	Verbesserte reaktivsysteme und/oder polymermassen fuer den gewebekontakt mit dem lebenden koerper

1991
- 1991-04-17 DE DE4112464A patent/DE4112464A1/de not_active Withdrawn
1992
- 1992-04-11 BR BR9205903A patent/BR9205903A/pt not_active Application Discontinuation
- 1992-04-11 DE DE59205311T patent/DE59205311D1/de not_active Expired - Fee Related
- 1992-04-11 ES ES92908734T patent/ES2083167T3/es not_active Expired - Lifetime
- 1992-04-11 JP JP50765592A patent/JP3351523B2/ja not_active Expired - Fee Related
- 1992-04-11 AT AT92908734T patent/ATE133857T1/de not_active IP Right Cessation
- 1992-04-11 US US08/133,205 patent/US5538738A/en not_active Expired - Fee Related
- 1992-04-11 EP EP92908734A patent/EP0580689B1/de not_active Expired - Lifetime
- 1992-04-11 DK DK92908734.4T patent/DK0580689T3/da active
- 1992-04-11 AU AU15760/92A patent/AU661303B2/en not_active Ceased
- 1992-04-11 CA CA002108680A patent/CA2108680A1/en not_active Abandoned
- 1992-04-11 WO PCT/EP1992/000825 patent/WO1992018108A1/de active IP Right Grant
1993
- 1993-09-20 NO NO933345A patent/NO933345D0/no unknown
- 1993-10-15 FI FI934569A patent/FI934569A0/fi unknown
1996
- 1996-04-02 GR GR960400911T patent/GR3019522T3/el unknown

Also Published As

Publication number	Publication date
DK0580689T3 (da)	1996-06-17
JPH06506672A (ja)	1994-07-28
AU1576092A (en)	1992-11-17
EP0580689A1 (de)	1994-02-02
FI934569A (fi)	1993-10-15
US5538738A (en)	1996-07-23
BR9205903A (pt)	1994-07-05
DE4112464A1 (de)	1992-10-22
DE59205311D1 (de)	1996-03-21
NO933345L (no)	1993-09-20
ATE133857T1 (de)	1996-02-15
FI934569A0 (fi)	1993-10-15
WO1992018108A1 (de)	1992-10-29
JP3351523B2 (ja)	2002-11-25
AU661303B2 (en)	1995-07-20
EP0580689B1 (de)	1996-02-07
ES2083167T3 (es)	1996-04-01
CA2108680A1 (en)	1992-10-18
NO933345D0 (no)	1993-09-20

Publication	Publication Date	Title
GR3019522T3 (en)	1996-07-31	Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material
DK88385A (da)	1985-02-27	Biologisk nedbrydeligt polypeptid samt anvendelse deraf til gradvis frigivelse af laegemidler
NZ236002A (en)	1993-01-27	Transdermal delivery system for 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
ATE146360T1 (de)	1997-01-15	Gonadotropin enthaltende gefriergetrocknete troepfen
AU4718496A (en)	1996-09-11	Use of aerogels in agriculture
GEP20043375B (en)	2004-11-25	APRIL-Receptor (BCMA) and Use Thereof
ATE192338T1 (de)	2000-05-15	Pharmazeutisches präparat zur synergistischen aktivierung natürlicher killerzellen
DE69213739D1 (de)	1996-10-17	Osteogene proteine enthaltende arzneimittel
HUT73197A (en)	1996-06-28	Polymer compositions, storage compositions, processes for producing thereof and articles produced therefrom
BG101278A (en)	1997-12-30	Hard systems designed for controlled release of moleculesintroduced in them and methods for their preparation
DE69812711D1 (de)	2003-04-30	Kohlenhydraten verwendbar in feste verabreichungssysteme
MX9805191A (es)	1998-10-31	Sistema, metodo y dispositivo para liberar de manera controlada un producto.
DK0609280T3 (da)	1999-10-25	Humane IL-3 varianter
DE69311541D1 (de)	1997-07-17	Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
DE69623652D1 (de)	2002-10-17	Formulierung zur peptidfreisetzung
DE69943225D1 (de)	2011-04-07	Flüssige Polymerlosung zur Kontrollierten freisetzung von bioaktiven substanzen
MX9709606A (es)	1998-06-30	Sistema liquido de liberacion controlada y de viscosidad elevada.
Ewing	1991	Studies on a novel gonadotropin binding inhibitor: Purification, identification and biological characterization of lipopolysaccharide from Serratia liquefaciens.